Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.

T Sumizawa, Z S Chen, Y Chuman, K Seto, T Furukawa, M Haraguchi, A Tani, N Shudo, S I Akiyama

Institute for Cancer Research, Faculty of Medicine, Kagoshima University, Japan.

Molecular pharmacology 1997 Mar

filter terms:

Three agents, verapamil, cepharanthine, and 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl-5-(trans-4,6-dimethyl-1, 3,2-dioxaphosphorinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-3-py ridinecarboxylate P-oxide (PAK-104P), that reverse drug resistance in P-glycoprotein (P-Gp)-mediated multidrug-resistant cells were examined for their activity to reverse drug resistance in multidrug resistance-associated protein (MRP)-mediated multidrug-resistant C-A120 cells. Agents other than PAK-104P could not reverse the resistance to doxorubicin in C-A120 cells. PAK-104P moderately reversed the doxorubicin resistance. In contrast, PAK-104P almost completely reversed the resistance to vincristine (VCR) in C-A120 cells as well as in KB-8-5 cells, and other agents moderately reversed the VCR resistance in C-A120 cells. PAK-104P at 10 microM enhanced the accumulation of VCR in C-A120 cells to the level of that in KB-3-1 cells without the agent. PAK-104P competitively inhibited the ATP-dependent [3H]leukotriene C4 uptake in membrane vesicles isolated from C-A120 cells. These findings demonstrate that PAK-104P can completely reverse the resistance to VCR in both P-Gp- and MRP-mediated multidrug-resistant cells and that PAK-104P directly interacts with MRP and inhibits the transporting activity of MRP.

Citation

T Sumizawa, Z S Chen, Y Chuman, K Seto, T Furukawa, M Haraguchi, A Tani, N Shudo, S I Akiyama. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Molecular pharmacology. 1997 Mar;51(3):399-405